Ancillary & Wellness · Tablet / Capsule
Avanafil is a phosphodiesterase type 5 inhibitor studied in men with erectile dysfunction. It is a nonhormonal small molecule whose action supports an existing nitric-oxide signal. A drug's onset study and its longer-term clinical outcomes answer different questions; a timing-related observation alone cannot establish superior overall effectiveness or cardiovascular safety.
Loading reports…
By reducing PDE5-mediated cyclic GMP breakdown, avanafil promotes smooth-muscle relaxation in erectile tissue during sexual stimulation. In-vitro comparisons show preferential PDE5 inhibition relative to several other phosphodiesterase families. These assays describe enzyme selectivity under controlled conditions. They do not replace clinical measurement of headaches, blood-pressure changes, visual symptoms or other adverse events in participants with different underlying diseases.
Specifications and prices per listed pack. USD.